Addex Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Addex Therapeutics has a total shareholder equity of CHF12.7M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF13.7M and CHF1.0M respectively.
Key information
0%
Debt to equity ratio
CHF 0
Debt
| Interest coverage ratio | n/a |
| Cash | CHF 3.79m |
| Equity | CHF 12.65m |
| Total liabilities | CHF 1.05m |
| Total assets | CHF 13.70m |
Recent financial health updates
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
Mar 03
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
May 11Recent updates
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
Mar 03Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
May 11Is Addex Therapeutics (VTX:ADXN) In A Good Position To Invest In Growth?
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Addex Therapeutics Ltd (VTX:ADXN)
Jun 10Financial Position Analysis
Short Term Liabilities: ADXN's short term assets (CHF4.7M) exceed its short term liabilities (CHF943.0K).
Long Term Liabilities: ADXN's short term assets (CHF4.7M) exceed its long term liabilities (CHF102.9K).
Debt to Equity History and Analysis
Debt Level: ADXN is debt free.
Reducing Debt: ADXN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ADXN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ADXN has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 16.3% each year.